Wolter Kluwer CEO Nancy McKinstry announces retirement in early 2026, Stacey Caywood nominated as successor
Wolters Kluwer (WTKWY) has announced that CEO Nancy McKinstry will retire in February 2026 after a highly successful tenure marked by a more than tenfold increase in the company's market capitalization. Stacey Caywood, current CEO of Wolters Kluwer Health, has been nominated as her successor.
The Supervisory Board will present Caywood's nomination at the Annual General Meeting of Shareholders on May 15, 2025. Caywood brings over thirty years of leadership experience within the company, including successful roles as CEO of Wolters Kluwer Health since 2020 and previous leadership of Wolters Kluwer Legal & Regulatory. She has demonstrated expertise in business transformation, digital revenue growth, and innovation across legal, compliance, and healthcare markets.
Wolters Kluwer (WTKWY) ha annunciato che il CEO Nancy McKinstry si ritirerà a febbraio 2026 dopo un mandato di grande successo, caratterizzato da un aumento della capitalizzazione di mercato dell'azienda di oltre dieci volte. Stacey Caywood, attuale CEO di Wolters Kluwer Health, è stata nominata come sua successore.
Il Consiglio di Sorveglianza presenterà la nomina di Caywood all'Assemblea Generale Annuale degli Azionisti il 15 maggio 2025. Caywood porta con sé oltre trent'anni di esperienza dirigenziale all'interno dell'azienda, inclusi ruoli di successo come CEO di Wolters Kluwer Health dal 2020 e precedenti responsabilità nella leadership di Wolters Kluwer Legal & Regulatory. Ha dimostrato competenze nella trasformazione aziendale, nella crescita dei ricavi digitali e nell'innovazione nei mercati legali, di conformità e sanitari.
Wolters Kluwer (WTKWY) ha anunciado que la CEO Nancy McKinstry se retirará en febrero de 2026 después de un mandato muy exitoso, marcado por un aumento de más de diez veces en la capitalización de mercado de la empresa. Stacey Caywood, actual CEO de Wolters Kluwer Health, ha sido nominada como su sucesora.
El Consejo de Supervisión presentará la nominación de Caywood en la Junta General Anual de Accionistas el 15 de mayo de 2025. Caywood aporta más de treinta años de experiencia en liderazgo dentro de la empresa, incluidos roles exitosos como CEO de Wolters Kluwer Health desde 2020 y liderazgo previo en Wolters Kluwer Legal & Regulatory. Ha demostrado experiencia en transformación empresarial, crecimiento de ingresos digitales e innovación en los mercados legales, de cumplimiento y de atención médica.
Wolters Kluwer (WTKWY)는 CEO인 Nancy McKinstry가 2026년 2월에 퇴임할 것이라고 발표했습니다. 그녀의 재임 기간 동안 회사의 시장 가치가 10배 이상 증가하는 등 매우 성공적인 성과를 거두었습니다. Stacey Caywood, 현재 Wolters Kluwer Health의 CEO가 그녀의 후임자로 지명되었습니다.
감독 위원회는 2025년 5월 15일 주주 총회에서 Caywood의 지명을 발표할 예정입니다. Caywood는 2020년부터 Wolters Kluwer Health의 CEO로서 성공적인 역할을 포함하여 회사 내에서 30년 이상의 리더십 경험을 가지고 있습니다. 그녀는 법률, 규제 및 의료 시장에서 비즈니스 혁신, 디지털 수익 성장 및 혁신에 대한 전문성을 입증했습니다.
Wolters Kluwer (WTKWY) a annoncé que la PDG Nancy McKinstry prendra sa retraite en février 2026 après un mandat très réussi, marqué par une augmentation de plus de dix fois de la capitalisation boursière de l'entreprise. Stacey Caywood, actuelle PDG de Wolters Kluwer Health, a été nommée comme sa successeur.
Le Conseil de Surveillance présentera la nomination de Caywood lors de l'Assemblée Générale Annuelle des Actionnaires le 15 mai 2025. Caywood apporte plus de trente ans d'expérience en leadership au sein de l'entreprise, y compris des rôles réussis en tant que PDG de Wolters Kluwer Health depuis 2020 et une précédente direction de Wolters Kluwer Legal & Regulatory. Elle a démontré son expertise dans la transformation des entreprises, la croissance des revenus numériques et l'innovation dans les marchés juridiques, de conformité et de santé.
Wolters Kluwer (WTKWY) hat bekannt gegeben, dass die CEO Nancy McKinstry im Februar 2026 nach einer äußerst erfolgreichen Amtszeit, die durch eine mehr als zehnfache Steigerung der Marktkapitalisierung des Unternehmens gekennzeichnet ist, in den Ruhestand gehen wird. Stacey Caywood, die derzeitige CEO von Wolters Kluwer Health, wurde als ihre Nachfolgerin nominiert.
Der Aufsichtsrat wird Caywoods Nominierung auf der Hauptversammlung der Aktionäre am 15. Mai 2025 vorstellen. Caywood bringt über dreißig Jahre Führungserfahrung im Unternehmen mit, einschließlich erfolgreicher Rollen als CEO von Wolters Kluwer Health seit 2020 und vorheriger Leitung von Wolters Kluwer Legal & Regulatory. Sie hat ihre Expertise in der Geschäftstransformation, im digitalen Umsatzwachstum und in der Innovation in den Bereichen Recht, Compliance und Gesundheitswesen unter Beweis gestellt.
- Market cap increased more than 10x under McKinstry's leadership
- Seamless leadership transition planned with 1-year notice
- New CEO nominee has 30+ years internal experience
- Incoming CEO led two major divisions successfully
- None.
PRESS RELEASE
Wolter Kluwer CEO Nancy McKinstry announces retirement in early 2026,
Stacey Caywood nominated as successor
Alphen aan den Rijn – February 26, 2025 – Wolters Kluwer (Euronext: WKL) announces today that after a very successful tenure as the CEO and Chair of the Executive Board of Wolters Kluwer, Nancy McKinstry has decided to retire in February 2026. At the Annual General Meeting of Shareholders on May 15, 2025, the Supervisory Board will nominate Stacey Caywood, current CEO of Wolters Kluwer Health, as a member of the Executive Board, with the intention of appointing her as CEO of Wolters Kluwer in February 2026.
“On behalf of the entire Supervisory Board, I would like to extend our heartfelt congratulations to Nancy McKinstry on her well-deserved retirement next year. Nancy's visionary leadership and unwavering dedication have been instrumental in driving Wolters Kluwer’s success, which has been recognized in many ways but perhaps most notably by a more than tenfold increase in the company’s market capitalization during her time as CEO. We are immensely grateful for the strong foundation she has built at Wolters Kluwer and for her commitment to ensuring an orderly and seamless transition, said Ann Ziegler, Chair of the Wolters Kluwer Supervisory Board.
“We are delighted to nominate Stacey Caywood as Wolters Kluwer CEO, effective February 2026,” Ms. Ziegler added. “Stacey's successful track record leading two of our largest divisions, her deep understanding of our business, and her active role in developing the group’s 2025-2027 strategic plan make her the ideal candidate to lead the company into the future. For over thirty years, Stacey has held various leadership roles within the company, and we have full confidence in her ability to continue Wolters Kluwer’s legacy of sustainable value creation through excellence and innovation. We look forward to working closely with Stacey and supporting her in this new role.”
"It has been an honor and privilege to lead Wolters Kluwer through decades of transformation as the market has evolved, and I am committed to ensuring the company’s continued strength and relevance," said Ms. McKinstry. "I am deeply grateful to the Board and my past and present colleagues for their support throughout my tenure. We have a strong foundation in place and, with Stacey, an extraordinarily talented and experienced successor. Stacey’s track record as a leader, her customer-focused approach, and her deep knowledge of our company gives me full confidence that Wolters Kluwer will be in excellent hands under her leadership. I am dedicated to ensuring a seamless transition over the next year."
Stacey Caywood, CEO of Wolters Kluwer Health since 2020, has led the further evolution and development of Wolters Kluwer’s healthcare solutions, ensuring medical and nursing professionals around the world can benefit from advanced clinical technology and evidence-based data and insights. Previously, as CEO of Wolters Kluwer Legal & Regulatory, she led a strategic transformation across Europe and the U.S., returning the business to organic growth. Ms. Caywood is a seasoned executive with extensive experience; she excels in business transformation, digital revenue growth, and innovation across legal, compliance, and healthcare markets. Her expertise spans strategy execution, portfolio management and M&A, product innovation, and commercial excellence.
After appointment by Wolters Kluwer's shareholders at the Annual General Meeting on May 15, 2025, the Executive Board of Wolters Kluwer N.V. will consist of Nancy McKinstry (CEO, until February 2026), Kevin Entricken (CFO) and Stacey Caywood.
For more information about Wolters Kluwer, please visit: www.wolterskluwer.com.
###
About Wolters Kluwer
Wolters Kluwer (Euronext: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of
The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50 and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
| Media | Investors/Analysts |
| Stefan Kloet | Meg Geldens |
| Associate Director | Vice President |
| Global Communications | Investor Relations |
| press@wolterskluwer.com | ir@wolterskluwer.com |
| m: +31 6 12 22 36 57 |
Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; conditions created by pandemics; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Elements of this press release contain or may contain inside information about Wolters Kluwer within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU). Trademarks referenced are owned by Wolters Kluwer N.V. and its subsidiaries and may be registered in various countries.
Attachment
FAQ
When will Nancy McKinstry step down as Wolters Kluwer (WTKWY) CEO?
Who will replace Nancy McKinstry as the new CEO of WTKWY?
What was Nancy McKinstry's impact on WTKWY market value during her tenure?
What is Stacey Caywood's experience at Wolters Kluwer (WTKWY)?
